Sirolimus Solution
Product Images NDC 72162-2641

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 72162-2641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622641)

Label for Sirolimus oral solution, 1 mg/mL, for oral use. The label shows a 60 mL bottle volume, with refrigeration requirements at 2°C to 8°C, and directions to use the contents within 1 month after opening. It is relabeled by Bryant Ranch Prepack and manufactured by MSN Pharmaceuticals. The label includes barcodes and QR codes for package insert and prescribing information.*

FDA Label Image

Sirolimus-fig-1 (Sirolimus Fig 1)

A line graph depicting the effect of sirolimus versus placebo on FEV1 (L) over 24 months. The x-axis represents months (0 to 24) divided into treatment and observation phases, while the y-axis shows FEV1 values from 0.0 to 1.6 L. Data points for sirolimus and placebo include error bars, with sample sizes noted below the x-axis for each month.*

FDA Label Image

Sirolimus-instruction-fig-1 (Sirolimus Instruction Fig 1)

A black and white instructional illustration showing two steps to open a child-resistant cap on a small bottle. The first step shows the bottle with a closed cap. The second step demonstrates a hand pressing down on the cap and turning it counterclockwise to open.*

FDA Label Image

Sirolimus-instruction-fig-2 (Sirolimus Instruction Fig 2)

An instructional black-and-white line drawing showing a hand holding a small glass vial with a dropper inside, and a downward arrow indicating to push or press down on the vial or dropper. The image appears to demonstrate handling or preparing the oral solution.*

FDA Label Image

Sirolimus-instruction-fig-3 (Sirolimus Instruction Fig 3)

An instructional illustration showing a two-step process for using an oral solution syringe with a vial. The first panel depicts a hand pressing the syringe plunger down. The second panel shows the syringe being inserted into a vial with the plunger being pushed further downward, indicating medication withdrawal.*

FDA Label Image

Sirolimus-instruction-fig-4 (Sirolimus Instruction Fig 4)

An instructional diagram showing two hands holding a vial and a syringe. The syringe is being pulled upward from the vial, with an inset highlighting a marked level on the syringe, indicating how to measure the liquid solution accurately before oral administration.*

FDA Label Image

Sirolimus-instruction-fig-5 (Sirolimus Instruction Fig 5)

An instructional illustration showing hands preparing an oral syringe by removing a cap from its tip, indicating preparation for dosing sirolimus oral solution.*

FDA Label Image

Sirolimus-instructions-fig-6 (Sirolimus Instruction Fig 6)

An instructional line drawing showing a hand holding a syringe over a rectangular tray with an indentation to hold the syringe. The illustration appears to demonstrate handling or preparing a syringe, possibly related to medication administration.*

FDA Label Image

Sirolimus-instruction-fig-7 (Sirolimus Instruction Fig 7)

An instructional illustration showing a syringe above a transparent measuring cup containing liquid, with an arrow indicating the syringe is drawing liquid from the cup. The image suggests proper administration steps for a liquid oral solution.*

FDA Label Image

Sirolimus-instruction-fig (Sirolimus Instruction Fig)

An illustration showing components of the sirolimus oral solution packaging and administration kit. It depicts a bottle (a), a medicine dropper cap (b), two dosing syringes (c), and an open box (d) designed to hold these components.*

FDA Label Image

Sirolimus-structure (Sirolimus Structure)

Chemical structure diagram of sirolimus, showing the molecular configuration with labeled stereochemistry and various functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.